C Kathleen Dorey

Title: C Kathleen Dorey: Innovator in Ocular Treatments

Introduction

C Kathleen Dorey is a prominent inventor based in Roanoke, VA (US), known for her significant contributions to the field of ocular health. With a focus on developing innovative materials and methods for treating pathological neovascularization in the eye, she has made strides in addressing critical ocular conditions.

Latest Patents

C Kathleen Dorey holds 2 patents that focus on the prevention of pathological proliferation of blood vessels in the eye. Her latest patents provide materials and methods that are particularly advantageous for treating conditions such as age-related macular degeneration (AMD), retinopathy of prematurity (ROP), and diabetic retinopathy. The inventions utilize gene therapy to effectively treat pathological ocular neovascularization, offering new hope for patients suffering from these debilitating conditions.

Career Highlights

Dorey is affiliated with Florida Atlantic University, where she continues her research and development efforts. Her work has garnered attention for its potential to transform treatment approaches in ophthalmology.

Collaborations

Throughout her career, C Kathleen Dorey has collaborated with notable colleagues, including Janet C Blanks and Howard Malcolm Prentice, enhancing the impact of her research through teamwork and shared expertise.

Conclusion

C Kathleen Dorey stands out as an influential inventor in the field of ocular treatments, with her innovative patents paving the way for advancements in the management of serious eye conditions. Her contributions are vital to improving patient outcomes and advancing medical science.